Clinical Trials · NCT04585932

Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study

Name: Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

WithdrawnPhase 2Gonadorelin

Phase: Phase 2
Recruitment status: Withdrawn
Sponsor: M.D. Anderson Cancer Center
Enrollment: 0
Start date: Nov 2020
Locations: 1 site, United States
Primary endpoint: Time to prostate specific antigen (PSA) recurrence

View Gonadorelin compound reference